F|DCFPyL|PET/CT in Men with Biochemically Recurrent Prostate ...

Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men ... - PubMed

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter ...

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with ...

Current FDA-approved imaging modalities are inadequate for localizing prostate cancer biochemical recurrence (BCR). 18F-DCFPyL is a highly selective, ...

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with ...

AbstractPurpose:. Current FDA-approved imaging modalities are inadequate for localizing prostate cancer biochemical recurrence (BCR). 18F-DCFPyL is a.

18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically ...

In conclusion, in this prospective trial of men with newly diagnosed and biochemically recurrent (BCR) prostate cancer, 2-(3-{1-carboxy-5-[(6-[( ...

18 F-DCFPyL PET/CT in Men with Prostate Cancer - RSNA Journals

In total, 23 men with newly diagnosed disease and 37 men with biochemically recurrent disease underwent biopsy. Six of the 23 men with newly ...

18F-DCFPyL PET/CT Imaging in Patients with Biochemically ...

F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy ... A 63-y-old man with T3aN0, ...

F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate ...

Purpose: Current FDA-approved imaging modalities are inad- equate for localizing prostate cancer biochemical recurrence (BCR). 18F-DCFPyL is a highly selective, ...

PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts ...

PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)—A subanalysis of ...

Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically ...

Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate ... men with biochemical failure after radical prostatectomy ...

Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of ...

... men with biochemically recurrent prostate cancer after radical prostatectomy. Clin Genitourinary Cancer. (2019) 17:470–5 e1. doi: 10.1016/j ...

Diagnostic Performance of F-DCFPyL-PET/CT in Men ... - theMednet

Current FDA-approved imaging modalities are inadequate for localizing prostate cancer biochemical recurrence (BCR). F-DCFPyL is a highly selective, ...

18F-DCFPyL PET/CT Imaging in Patients with Suspected ...

CONDOR phase III trial examining the diagnostic performance of 18F-DCFPyL PET/CT in men with biochemically recurrent prostate cancer, ...

In Biochemically Recurrent Prostate Cancer, PSMA-Targeted PET ...

The study shows that PyL–PET/CT is superior to standard imaging in men with biochemically recurrent prostate cancer.

Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on ...

... biochemically recurrent (BCR) prostate cancer (PCa): Results from ... PET/CT in men with suspected recurrence of prostate cancer (CONDOR).

A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in ...

... imaging pelvis) for men with radio-recurrent prostate cancer. ... A prospective study on 18 F-DCFPyL PSMA PET/CT imaging in biochemical recurrence ...

Detection of Biochemically Recurrent Prostate Cancer with [ 18 F ...

... F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer. J. Nucl. Med. 2020, 61, 58–61. [Google ...

18F-Fluciclovine PET/CT performance in biochemical recurrence of ...

A systematic literature review of the performance of 18Fluorine-fluciclovine PET/CT for imaging of men with recurrent prostate cancer was ...

[ 18 F]DCFPyL PET/CT versus [ 18 F]fluoromethylcholine PET/CT in ...

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III.

18F-DCFPyL PET/CT Imaging for Suspected Recurrent Prostate ...

The biggest thing I see in my practice is patients with biochemical recurrence with the lowest PSA who are able to do salvage radiation or ...

Complex implementation factors demonstrated when evaluating cost ...

Application of next-generation imaging in biochemically recurrent prostate cancer ... F]DCFPyL PET/CT in prostate cancer men. Sci Rep 13, 8321 ( ...